SI-BONE, Inc. (SIBN)

Market Cap	637.31M +6.9%
Revenue (ttm)	200.93M +20.2%
Net Income	-18.90M
EPS	-0.44
Shares Out	44.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	656,992
Open	14.00
Previous Close	14.00
Day's Range	13.85 - 14.59
52-Week Range	12.15 - 21.89
Beta	0.77
Analysts	Strong Buy
Price Target	24.13 (+67.22%)
Earnings Date	May 4, 2026

About SIBN

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the impla...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 17, 2018
• Employees: 376
• Stock Exchange: NASDAQ
• Ticker Symbol: SIBN
• Website: https://si-bone.com

Financial Performance

In 2025, SI-BONE's revenue was $200.93 million, an increase of 20.19% compared to the previous year's $167.18 million. Losses were -$18.90 million, -38.85% less than in 2024.

Analyst Summary

According to 8 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price target is $24.13, which is an increase of 67.22% from the latest price.

Price Target

$24.13

(67.22% upside)

Analyst Consensus: Strong Buy